Home/Filings/4/0001209191-23-032671
4//SEC Filing

Bray June 4

Accession 0001209191-23-032671

CIK 0001662774other

Filed

May 25, 8:00 PM ET

Accepted

May 26, 5:45 PM ET

Size

9.4 KB

Accession

0001209191-23-032671

Insider Transaction Report

Form 4
Period: 2023-05-24
Bray June
Director
Transactions
  • Award

    Stock Option (right to buy)

    2023-05-24+27,00027,000 total
    Exercise: $1.58Exp: 2033-05-23Common Stock (27,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the stock option shall vest in equal annual installments over the three-year period following the grant date of May 24, 2023.

Issuer

Quince Therapeutics, Inc.

CIK 0001662774

Entity typeother

Related Parties

1
  • filerCIK 0001845487

Filing Metadata

Form type
4
Filed
May 25, 8:00 PM ET
Accepted
May 26, 5:45 PM ET
Size
9.4 KB